The novel compound 3-(1H-benzimidazol-2-yl)-5-isoquinolin-4-ylpyrazolo [1, 2-b] pyridine was discovered to be a potent CDK1 inhibitor. Described here is the chemistry for its synthesis, including Pd (II) catalyzed Stille coupling reaction and sulfur (0) induced benzimidazole formation. Its effects on VEGFR-2 kinase activity and tumour cell proliferation are also described.